| Medicine | Active substance | Licence holder | Status |
|---|
| BUCCOLAM 10 mg oromucosal solution EU/1/11/709/004 |
Midazolam |
Laboratorios Lesvi, S.L. |
— |
| BUCCOLAM 2.5 mg oromucosal solution EU/1/11/709/001 |
Midazolam |
Laboratorios Lesvi, S.L. |
— |
| BUCCOLAM 5 mg oromucosal solution EU/1/11/709/002 |
Midazolam |
Laboratorios Lesvi, S.L. |
— |
| BUCCOLAM 7.5 mg oromucosal solution EU/1/11/709/003 |
Midazolam |
Laboratorios Lesvi, S.L. |
— |
| Buprenorphine Neuraxpharm EU/1/24/1809/001-003 |
Buprenorphine hydrochloride |
Laboratorios Lesvi, S.L. |
— |
| Buprenorphine Neuraxpharm EU/1/24/1809/004-006 |
Buprenorphine hydrochloride |
Laboratorios Lesvi, S.L. |
— |
| Buprenorphine Neuraxpharm EU/1/24/1809/007-009 |
Buprenorphine hydrochloride |
Laboratorios Lesvi, S.L. |
— |
| Buprenorphine Neuraxpharm EU/1/24/1809/010-012 |
Buprenorphine hydrochloride |
Laboratorios Lesvi, S.L. |
— |
| Tuzulby 20 mg prolonged-release chewable tablets EU/1/24/1907/001 |
Methylphenidate hydrochloride |
Laboratorios Lesvi, S.L. |
— |
| Tuzulby 30 mg prolonged-release chewable tablets EU/1/24/1907/002 |
Methylphenidate hydrochloride |
Laboratorios Lesvi, S.L. |
— |
| Tuzulby 40 mg prolonged-release chewable tablets EU/1/24/1907/003 |
Methylphenidate hydrochloride |
Laboratorios Lesvi, S.L. |
— |
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.